Χουρμούζιος Αραμπατζής

MD, PhD, FESC

Επεμβατικός Καρδιολόγος,
Ειδικός στην πρόληψη και αντιμετώπιση της Στεφανιαίας Νόσου

Ο Χουρμούζιος Αραμπατζής σπούδασε Ιατρική στο Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης και ειδικεύτηκε στην Καρδιολογία στο Νοσοκομείο Γ. Παπανικολάου. Στη συνέχεια, εξειδικεύτηκε το διάστημα 2002-2004 στην Επεμβατική Καρδιολογία στο Thoraxcenter του Ρόττερνταμ Ολλανδίας, όπου εκπόνησε και την διδακτορική του διατριβή.

Το ενδιαφέρον του εστιάζεται στην αντιμετώπιση και πρόληψη της στεφανιαίας νόσου. Έχει συμμετάσχει σε πολλές πρωτοποριακές μελέτες για τα επικαλυμμένα stent και έχει εκδώσει ένα βιβλίο για τη σύγχρονη αντιμετώπιση της στεφανιαίας νόσου. Στην Ελλάδα πραγματοποιεί τις επεμβάσεις του στο Ιατρικό Διαβαλκανικό Κέντρο όπου είναι Διευθυντής Καρδιολογικής Κλινικής και έχει πραγματοποιήσει πάνω από 7.000 επεμβάσεις. Διατηρεί ιατρείο στο κέντρο της Θεσσαλονίκης.

Μητροπόλεως 119, 546 22 Θεσσαλονίκη,
T +30 2310 238188, +30 2310 400000, Κ +30 6944 323525

ΕΚΠΑΙΔΕΥΣΗ

1986-1992
Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης
1986-1992
2000-2002

Μάστερ στην Ιατρική Έρευνα και Τεχνολογία (MSc), Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης

2000-2002
2002-2004

Διδακτορική Διατριβή (Thesis) με τίτλο «Novel Percutaneous Therapies for Complex Coronary Atherosclerosis», Erasmus University, Rotterdam

2002-2004

ΜΕΤΕΚΠΑΙΔΕΥΣΗ-ΕΞΕΙΔΙΚΕΥΣΗ

1996-1998

Ειδικευόμενος Παθολογίας, 1Ο Γενικό Νοσοκομείο Άγιος Παύλος, Θεσσαλονίκη

1996-1998
1998-2002

Ειδικευόμενος Καρδιολογίας, Γενικό Νοσοκομείο Παπανικολάου, Θεσσαλονίκη

1998-2002
2002-2004

Clinical and research fellow in Interventional Cardiology, Thorax Center, Erasmus University, Rotterdam /
Πρωτοποριακή δουλειά με επικαλυμμένα stent, σύμπλοκες αγγειοπλαστικές, χρήση τεχνολογίας στο αιμοδυναμικό εργαστήριο (FFR, IVUS, OCT) συμμετοχή σε πολυκεντρικές μελέτες.

2002-2004

ΕΜΠΕΙΡΙΑ

2004-2005

Επεμβατικός Καρδιολόγος, Κλινική Κυανός Σταυρός, Θεσσαλονίκη

2004-2005
2005 –
Επεμβατικός Καρδιολόγος, Ιατρικό Διαβαλκανικό Κέντρο, Θεσσαλονίκη
2005 –
2005 –
Καρδιολόγος, Ιδιωτικό ιατρείο διάγνωσης και θεραπείας Καρδιολογικών ασθενών, Θεσσαλονίκη
2005 –

ΕΡΕΥΝΑ, ΔΗΜΟΣΙΕΥΣΕΙΣ, ΔΙΔΑΚΤΙΚΟ ΕΡΓΟ

  • Δείκτης Η index 26, i-10 Index 34 με περισσότερες από 4.500 αναφορές (citations) στην εργασία του.
  • Σύμβουλος έκδοσης (Associate Editor) στο περιοδικό του Ελληνικού Κολλεγίου Καρδιολογίας Continuous Cardiology Education.
  • Συμμετοχή σε Καρδιολογικά Συνέδρια ως Ομιλητής ή/και ως Πρόεδρος από το 2004 μέχρι σήμερα.

ΕΚΔΟΤΙΚΟ ΕΡΓΟ

  1. Coronary Atherosclerosis Current Management and Treatment, Arampatzis (Editor in chief), McFadden, Michalis, Virmani και Serruys, Informa 2012

PROFESSIONAL MEMBERSHIPS

  1. Hellenic National Society of Cardiologists
  2. Fellow of the European Society of Cardiology – FESC
  3. Fellow of European Association of Percutaneous Cardiovascular Interventions – FEAPCI
  4. BIG register – Dutch HealthCare Professionals
  5. KNMG – Royal Dutch Medical Association

ORIGINAL REPORTS (peer reviewed articles)

  1. Graft failure prior to discharge after coronary artery bypass surgery: a prospective single-centre study using dual 64-slice computed tomography.
    Arampatzis CA, Chourmouzi D, Boulogianni G, Lemos P, Pentousis D, Potsi S, Moumtzouoglou A, Papadopoulou E, Grammenos A, Voucharas C, Mpismpos A, McFadden EP, Drevelengas A. EuroIntervention 2016 Oct 10;12(8):e972-e978.
  2. Organization, structure and data of the Hellenic Heart Registry on Percutaneous Coronary Interventions: a step forward towards outcomes research.
    Papaioannou GI, Chatzis DG, Kotsanis A, Sionis DG, Pavlides G, Arampatzis CA, Tziakas DN, Lees PJ, Mihalis L; Working Group of Hemodynamics and Interventional Cardiology, Hellenic Society of Cardiology. Hellenic J Cardiol. 2014 May-Jun;55(3):227-34.
  3. A prospective, randomized trial of Intravascular-ultrasound guided compared to Angiography Guided Stent Implantation in Complex Coronary Lesions: The Avio Trial.
    Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A, Varbella F, Mauri F, Valgimigli M, Arampatzis C, Sabate M, Erglis A, Reimers B, Airoldi F, Laine M, Palop RL, Mikhail G, Maccarthy P, Romeo F, Colombo A. American Journal of Cardiology 2013 Jan;165(1):65-72.
  4. Percutaneous pulmonary valve implantation in the native right ventricular outflow tract.
    Thanopoulos BV, Giannakoulas G, Arampatzis CA. Catheter Cardiovasc Interv. 2012 Feb 15;79(3):427-9.
  5. Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease.
    Lemos PA, de Feyter PJ, Serruys PW, Saia F, Arampatzis CA, Disco C, Mercado N, Mainar V, Moris C, van den Bos AA, Berghoefer G. International Journal of Cardiology 2005 Feb 28;98(3):479-486.
  6. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT, Lemos PA, Takkenberg JJ, Liu TK, van Herwerden LA, Arampatzis CA, Smits PC, Daemen J, Venema AC, Serruys PW, Bogers AJ. European Heart Journal 2005 Apr;26(7):675-81
  7. Improved diagnostic accuracy with 16-row multi-slice computed tomography coronary angiography.
    Mollet NR, Cademartiri F, Krestin GP, McFadden EP, Arampatzis CA, Serruys PW, de Feyter PJ. J Am Coll Cardiol. 2005 Jan 4;45(1):128-32.
  8. Treatment of Coronary Artery Disease in Dialysis Patients with Sirolimus-eluting Stents: 1-year Clinical Follow-up of a Consecutive Series of Cases.
    Daemen J, Lemos P, Aoki J, Arampatzis C, Hoye A, McFadden E, Serruys P.  J Invasive Cardiol. 2004 Dec;16(12):685-7.
  9. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis. One-year clinical outcomes of 99 consecutive patients – The Rotterdam experience.
    Arampatzis CA, Hoye A, Lemos P, Saia F, Tanabe K, Degertekin M, Sianos G, Smits P, van der Giessen W, McFadden E, van Domburg R, de Feyter P, Serruys PW. Catheter Cardio Interventions 2004; 63(1): 57-60
  10. Elective sirolimus-eluting stent implantation for left main coronary artery disease-6 month angiographic follow-up and one-year clinical outcome.
    Arampatzis CA, Lemos P, Hoye A, Saia F, Tanabe K, Smits P, van der Giessen W, McFadden E, de Feyter P, Serruys PW. Catheter Cardio Interventions 2004; 62(3) 92-96
  11. Effectiveness of sirolimus-eluting stent implantation for treatment of left main coronary artery disease.
    Arampatzis CA, Lemos P, Tanabe K, Hoye A, Degertekin M, Saia F, Lee C, Ruiter A, Sianos G, Smits P, van der Giessen W, de Feyter P, van Domburg R, Serruys PW. American Journal of Cardiology 2003; 92:327-329
  12. Detection of a coronary vulnerable plaque: a treatment dilemma.
    Arampatzis CA, Ligthart J, Schaar J, Nieman K, Serruys PW, de Feyter P. Circulation 2003; 108: e34-35
  13. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention. A LIPS substudy.
    Arampatzis CA, Goedhart D, Saia F, Lemos P, Serruys PW, de Feyter P. American Heart Journal, 2005 Feb;149(2):329-35.
  14. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents.
    Lemos P, Arampatzis CA, Hoye A, Daemen J, Saia F, van der Giessen W, McFadden E, Sianos G, Smits P, de Feyter P, Hofma S, van Domburg R, Serruys PW. American Journal of Cardiology 2005 Jan 15;95(2):167-72.
  15. Treatment of very small vessels with 2.25mm diameter sirolimus eluting stents from the RESEARCH registry.
    Lemos P, Arampatzis CA, Saia F, Hoye A, Degertekin M, Tanabe K, Lee C, Cummins P, Smits P, McFadden E, Sianos G, de Feyter P, van der Giessen W, van Domburg R, Serruys PW. American Journal of Cardiology 2004;93:633-6.
  16. Very long sirolimus-eluting stent implantation for de novo coronary lesions.
    Degertekin M, Arampatzis CA, Lemos P, Saia F, Hoye A, Daemen J, Tanabe K, Lee C, Hofma S, Sianos G, McFadden E, van der Giessen W, Smits P, de Feyter P, van Domburg R, Serruys PW. American Journal of Cardiology 2004;93:826-9.
  17. Post-Sirolimus eluting stent restenosis treated with repeat percutaneous intervention: Late angiographic and clinical outcomes.
    Lemos P, van Mieghem C, Arampatzis CA, Hoye A, Ong A, McFadden E, Sianos G, Hofma S, Smits P, van der Giessen W, de Feyter P, van Domburg R, Serruys PW. Circulation. 2004 Jun 1;109(21):2500-2. Epub 2004 May 17
  18. Clinical and angiographic outcomes after over-dilatation of undersized sirolimus-eluting stents with largely oversized balloons. An observational study.
    Saia F, Lemos P, Arampatzis CA, Hoye A, McFadden E, Sianos G, Smits P, van der Giessen W, de Feyter P, van Domburg R, Serruys PW. Catheter Cardiovascular Interventions 2004;61(4) 455-460.
  19. Routine sirolimus-eluting stent implantation for unselected in-stent restenosis: Insights from The Rapamycin Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
    Saia F, Lemos P, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Lee C, Sianos G, Smits P, van der Giessen W, de Feyter P, Serruys PW. Heart 2004; 90 (10): 1183-8.
  20. Three year clinical outcome after coronary stenting or coronary artery bypass grafting in patients with multivessel disease involving proximal left anterior descending lesions – A subanalysis of the ARTS trial.
    Aoki J, Ong A, Arampatzis CA, Vijaykumar M, Rodriguez Granillo G, Disco C, Serruys PW. American Journal of Cardiology 2004 Sep 1;94(5):627-31.
  21. Sirolimus-eluting stent implantation for lesions with<50% diameter stenosis: implications for plaque stabilization.
    Hoye A, Lemos P, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Daemen J, Smits P, McFadden E, Sianos G, de Feyter P, van der Giessen W, Hofma S, van Domburg R, Serruys PW. American Journal of Cardiology 2004 Jul 1;94(1):112-4
  22. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. Results of the RESEARCH (The Rapamycin Eluting Stent Evaluated At Rotterdam Cardiology Hospital) registry.
    Hoye A, Lemos P, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Hofma S, McFadden E, Sianos G, Smits P, van der Giessen W, de Feyter P, van Domburg R, Serruys PW. J Invasive Cardiology 2004 May;16(5):230-3.
  23. Effectiveness of the sirolimus-eluting stent in the treatment of patients with prior history of coronary artery bypass graft surgery.
    Hoye A, Lemos P, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Hofma S, McFadden E, Sianos G, Smits P, van der Giessen W, de Feyter P, van Domburg R, Serruys PW. Coron Artery Dis. 2004 May;15(3):171-5.
  24. Clinical, Angiographic, and Procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients – An evaluation from the RESEARCH registry.
    Lemos P, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen W, McFadden E, Sianos G, Smits P, Hofma S, de Feyter P, van Domburg R, Serruys PW. Circulation 2004;109:1366-70
  25. Noninvasive visualisation of coronary atherosclerosis with multislice computed tomography.
    de Feyter P, Mollet N, Nieman K, Arampatzis CA, Cademartiri F, Pattynama P, Serruys PW. Cardiovasc Radiat Med. 2004 Jan-Mar;5(1):49-56.
  26. Coronary restenosis after sirolimus-eluting stent implantation: Morphological description and mechanistic analysis from a consecutive series of cases.
    Lemos P, Saia F, Ligthart J, Arampatzis CA, Sianos G, Tanabe K, Hoye A, Degertekin M, Daemen J, McFadden E, Hofma S, Smits P, de Feyter P, van der Giessen W, van Domburg R, Serruys PW. Circulation 2003; 108:257-260
  27. Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-year clinical follow-up of a consecutive series of cases.
    Daemen J, Lemos P, Aoki J, Arampatzis C, Hoye A, McFadden E, Serruys P. J Invasive Cardiol. 2004 Dec;16(12):685-7.
  28. Sirolimus-eluting stent implantation in ST– elevation acute myocardial infarction. A clinical and angiographic study.
    Saia F, Lemos P, Lee C, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits P, McFadden E, Hofma S, van der Giessen W, de Feyter P, van Domburg R, Serruys PW. Circulation 2003; 108:1927-1929
  29. Sirolimus-eluting stents for the treatment of in-stent restenosis.
    Degertekin M, Saia F, Lemos PA, Arampatzis CA, Serruys PW. Minerva Cardioangiol. 2003 Sep;51(5):475-84
  30. Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease.
    Lemos P, de Feyter P, Serruys PW, Saia F, Arampatzis CA, Disco C, Mercado N, Mainar V, Morís C, van den Bos A, Berghoefer G. Int J Cardiol. 2005 Feb 28;98(3):479-86.
  31. Restenosis rates following bifurcation stenting with sirolimus-eluting stent for de novo narrowing.
    Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, Lee Ch, Degertekin M, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW. American Journal of Cardiology 2004 Jul 1;94(1):115-8.
  32. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis.
    Saia F, Lemos PA, Hoye A, Sianos G, Arampatzis CA, de Feyter PJ, van der Giessen WJ, Smits PC, van Domburg RT, Serruys PW. Catheter Cardiovasc Interv. 2004 Jul;62(3):283-8.
  33. Unrestricted utilization of sirolimus-eluting stents compared to conventional bare stent implantation in the “real world”. A study of 1200 patients from the Rapamycin Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Lemos P, Serruys PW, van Domburg R, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu T, McFadden E, Sianos G, Hofma S, Smits P, van der Giessen W, de Feyter P. Circulation 2004; 109:190-5.
  34. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy.
    Saia F, Lemos P, Sianos G, Degertekin M, Lee C, Arampatzis CA, Hoye A, Tanabe K, Regar E, van der Giessen W, Smits P, de Feyter P, Ligthart J, van Domburg R, Serruys PW. American Journal of Cardiology 2003; 92:200-203
  35. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes – Insights from the Rapamycin Eluting Stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Lemos P, Lee C, Degertekin M, Saia F, Tanabe K, Arampatzis CA, Hoye A, van Drunen M, Sianos G, Smits P, de Feyter P, van der Giessen W, van Domburg R, Serruys PW. American Journal of Cardiology 2003;41:2093-2099
  36. Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation. 
    Saia F, de Feyter P, Serruys PW, Lemos P, Arampatzis CA, Hendrickx G, Delarche N, Goedhart D, Lesaffre E, Branzi A, for the Lescol Intervention Prevention Study (LIPS) Investigators. American Journal of Cardiology 2004 Jan 1;93(1):92-5
  37. Short- and Long-Term clinical benefit of Sirolimus-Eluting Stents Compared to Conventional Bare Stents for patients with Acute Myocardial Infarction
    Lemos P, Saia F, Hofma S, Daemen J, Ong A, Arampatzis CA, Hoye A, McFadden E, Sianos G, Smits P, van der Giessen W, de Feyter P, van Domburg R, Serruys PW. American Journal of Cardiology 2004;43:704-8
  38. Low restenosis following the use of sirolimus-eluting stents in the treatment of chronic total occlusions.
    Hoye A, Tanabe K, Lemos P, Aoki J, Saia F, Arampatzis CA, Degertekin M, Hofma S, Sianos G, McFadden E, van der Giessen W, Smits P, de Feyter P, van Domburg, Serruys PW. American Journal of Cardiology 2004 Jun 2;43(11):1954-8
  39. Imaging of coronary atherosclerosis and identification of the vulnerable plaque.
    de Feyter P, Serruys PW, Nieman K, Mollet N, Cademartiri F, van Geuns RJ, Slager C, van der Steen A.F.W, Krams R, Schaar J, Wielopolski P, Pattynama P.M.T, Arampatzis CA, van der Lugt A, Regar E, Ligthart J, Smits P. Netherlands Heart Journal, 11;9:347-358
  40. Long term fluvastatin abolishes the hazardous effect of renal impairment on 4-year atherosclerotic outcomes – A LIPS substudy.
    Lemos P, Serruys PW, de Feyter P, Mercado N, Goedhart D, Saia F, Arampatzis CA, Soares P, Ciccone M, Arquati M, Cortellaro M, Rutsch W, Legrand W.  American Journal of Cardiology 2005 Feb 15;95(4):445-51.
  41. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients.
    Regar E, Lemos PA, Saia F, Degertekin M, Tanabe K, Lee CH, Arampatzis CA, Hoye A, Sianos G, de Feyter P, van der Giessen WJ, Smits PC, van Domburg RT, Serruys PW. American Journal of Cardiology 2004 May 15;93(10):1271-5.
  42. Left atrial recordings during AV nodal reentrant tachycardia.
    Hatzinikolaou H, Arampatzis CA, Tsevekidis H, Koutsibanis G, Katsaris G, Hatseras D. Europace 2001, The European Working Groups on cardiac pacing and arrhythmias.

BOOK CHAPTERS

  1. Cell transplantation for myocardial repair. Current perspectives, clinical applications, and future directions.
    Arampatzis CA, Smits P, van der Giessen W, Geuns R, Poldermans D, de Feyter P, McFadden E, Serruys PW. In Marco J, Serruys PW, Biamino G, Fajadet J, de Feyter P, Morice MC (Eds): The Paris course on revascularization. Paris: Europa edition. 2004.
  2. Non-balloon technology in the DES era. (Rotablator, Atherectomy, Thrombectomy).
    Arampatzis CA, McFadden E, Sianos G, Saia F, Smits P, van der Giessen W, de Feyter P, Serruys PW. In Marco J, Serruys PW, Biamino G, Fajadet J, de Feyter P, Morice MC (Eds): The Paris course on revascularization. Paris: Europa edition. 2004.
  3. Diagnosis of vulnerable plaques in the cardiac catheterization laboratory.
    JA. Shaar, AFW van der Steen, C.A. Arampatzis, R. Krams, C.J.Slager, A.G. ten Have, S.W. van de Poll, F.J.Gijsen, J.J. Wentzel, P.J de Feyter. In Y. Saijo, A.F.W. van der Steen (Eds): Vascular Ultrasound. Springer-Verlag Tokyo 2003
  4. Immunoallergic syndromes in interventional cardiology.
    CA. Arampatzis, I. Kanonidis, PW Serruys In Lemos, Martinez, Ong, Serruys (Eds): Common Clinical Dilemmas in Percutaneous Coronary Interventions. 2007 Informa UK Ltd
  5. Coronary Anomalies and Fistulae. An overview of important entities.
    CA. Arampatzis, V Voudris In Lemos, Schoenhagen and Alexandra Lansky. Diagnostic methods in the catheterization laboratory: a practical approach for specific clinical situations. 2010 Informa UK Ltd

Assessment reports

  1. Molecular strategies for restenosis.
    Arampatzis CA. Aristotelian University of Thessaloniki, Department of Medical Informatics.

Published Abstracts

  1. Post-procedural cardiac enzyme elevation is associated with increased long-term (5-year) mortality following bypass surgery but not after multivessel stenting-insights from the randomized ARTS trial.
    A. Ong, C.A.Arampatzis, M.A. Costa, V.Voudris, W. Lindeboom, D.M.Goedhart, A.P.Kappetein, P.W.Serruys. In: European Society of Cardiology Congress 2005, Stockholm, Sweden.
  2. Fluvastatin safety profile in patients with low levels of ldl cholesterol in the Lescol® intervention prevention study.
    P. Lemos, C.A. Arampatzis, D. Goedhart, C. Gimpelewicz, M. Freudenreich, J.O. Logani, M. Bortolini and P. Serruys. Atherosclerosis Supplements, Volume 6, Issue 1, April 2005, Page 108
  3. Three year clinical outcome after coronary stenting or coronary artery bypass grafting in patients with multivessel disease involving proximal LAD lesions.
    Aoki J, Ong ATL, Arampatzis CA, Vijayakumar M, Rodriguez G, Disco C, Serruys PW. In: European Society of Cardiology Congress, 2004, Munich, Germany.
  4. Non-invasive multislice computer tomography coronary angiography.
    Mollet N.R.A., Cademartiri F, Krestin G.P., McFadden E, Arampatzis CA, Baks T, de Feyter P. In: European Society of Cardiology Congress, 2004, Munich, Germany.
  5. Restenosis after sirolimus-eluting stent implantation: Long term evaluation following repeat percutaneous intervention.
    Lemos PA, Arampatzis CA, Hoye A, Daemen J, Saia F, Ong ATL, Sianos G, Aoki J, Smits PC, van der Giessen WG, de Feyter P, McFadden E, Hofma SH, van Domburg RT, Serruys PW. In: American College of Cardiology – 53rd Annual Scientific Session, 2004, New Orleans, USA.
  6. Low repeat revascularization rates following drug-eluting stent implantation in de novo bifurcation lesions.
    Hoye A, Lemos PA, Tanabe K, Arampatzis CA, Saia F, Aoki J, Degertekin M, Ong ATL, van Mieghem C, Hofma SH, Sianos G, Smits PC, van der Giessen WG, McFadden E, de Feyter P, Serruys PW. In: American College of Cardiology- 53rd Annual Scientific Session, 2004, New Orleans, USA.
  7. Comparative incidence of angiographically proven early stent thrombosis in unselected sirolimus- and paclitaxel-eluting stent populations.
    Ong ATL, Lemos PA, Hoye A, Arampatzis CA, Saia F, Aoki J, van Mieghem C, Hofma SH, Smits PC, van der Giessen WG, Sianos G, McFadden E, de Feyter P, Serruys PW. In: American College of Cardiology – 53rd Annual Scientific Session, 2004, New Orleans, USA.
  8. Safety and feasibility of paclitaxel-eluting stents in the treatment of ST-elevation acute myocardial infarction.
    Ong ATL, Lemos PA, Hoye A, Arampatzis CA, Saia F, Aoki J, van Mieghem C, Hofma S, Smits P, van der Giessen W. Journal of the American College of Cardiology, Volume 43, Issue 5, Supplement 1, 3 March 2004, Page A251
  9. Similar clinical outcomes for sirolimus-eluting stent implantation and coronary brachytherapy for the treatment of in-stent restenosis.
    Saia F, Lemos PA, Hoye A, Sianos G, Arampatzis CA, van der Giessen WG, Smits PC, van Domburg RT, de Feyter P, Serruys PW. In: American College of Cardiology – 53rd Annual Scientific Session, 2004, New Orleans, USA.
  10. Unrestricted Utilization of Sirolimus-Eluting Stent Implantation in the “Real World” Reduces Events Compared with Previous Strategies Using Conventional Bare Stents – A Study of 1200 Consecutive Patients from the RESEARCH registry.
    Lemos PA, Saia F, Arampatzis CA, Hoye A, Tanabe K, Degertekin M, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, McFadden E, Hofma S, van Domburg RT, Serruys PW. Circulation 2003; 108 (17 [Suppl]): IV-532
  11. Comparison between sirolimus-eluting stents and conventional interventional strategies for patients with acute myocardial infarction – Results from the RESEARCH registry.
    Saia F, Lemos PA, Lee CH, Arampatzis CA, Hoye A, Tanabe K, Degertekin M, Smits PC, Sianos G, van der Giessen WJ, McFadden E, Hofma S, de Feyter P, van Domburg RT, Serruys PW. Circulation 2003; 108 (17 [Suppl]): IV-409
  12. Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.
    CA. Arampatzis, PA. Lemos and K. Tanabe. ACC Current Journal Review, Volume 12, Issue 6, November-December 2003, Pages 48-49
  13. Fluvastatin reduces the impact of diabetes on long term outcome after coronary intervention. A LIPS substudy.
    CA. Arampatzis, D. Goedheart, P.W.Serruys, P. J de Feyter. In: European Society of Cardiology Congress, Vienna, Austria.
  14. Sirolimus-eluting stents for the treatment of bifurcation lesions.
    Tanabe K, Arampatzis CA, Hoye A, Lemos PA, Sianos G, van der Giessen WG, van Domburg RT, Serruys PW. In: European Society of Cardiology Congress, Vienna, Austria.
  15. Sirolimus-eluting stent implantation in very small coronary vessels treated in the RESEARCH registry.
    Lemos PA, Arampatzis CA, Hoye A, Tanabe K, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW. In: European Society of Cardiology Congress, Vienna, Austria.
  16. Sirolimus-eluting stent implantation in acute myocardial infarction: results of the RESEARCH registry.
    Lee CH, Lemos PA, Arampatzis CA, Hoye A, Smits PC, van der Giessen WJ, van Domburg RT, Serruys PW. In: European Society of Cardiology Congress, Vienna, Austria.
  17. Low incidence of subacute stent thrombosis after sirolimus-eluting stent implantation in daily practice-results from the RESEARCH registry.
    Regar E, Lemos PA, Saia F, Tanabe K, Degertekin M, Arampatzis CA, van Domburg RT, Serruys PW. In: European Society of Cardiology Congress, Vienna, Austria.
  18. Very low incidence of acute and subacute thrombosis following sirolimus-eluting stent implantation in a large series of consecutive patients insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
    Hoye, Lemos, Regar, Saia, Degertekin, Arampatzis, Tanabe, Lee, van Domburg, Sianos, Smits, van der Giessen, de Feyter, Serruys. Heart, volume 89, suppl A54, 2003
  19. Sirolimus eluting stent implantation for restenosis following brachytherapy.
    Hoye, Saia, Degertekin, Lemos, Arampatzis, Tanabe, Lee, Sianos, Smits, Giessen, deFeyter, Serruys, van Domburg. Heart, volume 89, suppl A36, 2003
  20. The Impact of Sirolimus-Eluting Stents on the Outcome of Patients with bifurcation lesions.
    Tanabe, Lemos, Lee, Degertekin, Regar, Arampatzis, van Domburg, de Feyter, van der Giessen, Sianos, Smits, Cummins, Ruiter, Saia, Serruys. In American College of Cardiology- 52nd Annual Scientific Session, 2003 Chicago. JACC 2003; v41. p12.A.
  21. Sabacute Stent Thrombosis After Sirolimus-Eluting Stent Implantation in Daily Practice: Results From the Rapamycin Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry.
    Regar, Lemos, Lee, Saia, Degertekin, Arampatzis, de Feyter, van der Giessen, Sianos, Smits, van Domburg, Serruys. In American College of Cardiology- 52nd Annual Scientific Session, 2003 Chicago. JACC 2003; v41. p23.A.
  22. Sirolimus-eluting stents for treatment of in-stent restenosis in the real world: preliminary results from the RESEARCH registry.
    Saia, Lemos, Degertekin, Regar, Arampatzis, Lee, Tanabe, de Feyter, van der Giessen, Sianos, Smits, van Domburg, Serruys. In American College of Cardiology- 52nd Annual Scientific Session, 2003 Chicago. JACC 2003; v41. p53.A.
  23. Ultrashort-term heart rate variability increases and long-term variability decreases prior to spontaneous ventricular fibrillation.
    Hatzinikolaou H. Reppas E. Klebetsanis K. Arampatzis CA. Katsaris G. European Heart Journal vol.20 abstract suppl. 1999
  24. Acute and subacute thrombosis following sirolimus-eluting stents.
    CA.Arampatzis, G.Sianos, E.Regar, P.Lemos, A.Hoye, F.Saia, M.Degertekin, K.Tanabe, C.Lee, P.C.Smits, W.van derGiessen, P.deFeyter, R.vanDomburg, P.W.Serruys. Onassis Cardiac Center Course Book, 2003
  25. Sirolimus-eluting stents for treatment of myocardial infarction.
    CA.Arampatzis, G.Sianos, P.Lemos, M.Degertekin, F.Saia, A.Hoye, K.Tanabe, C.Lee, P.C.Smits, W.van derGiessen, P.deFeyter, R.vanDomburg, P.W.Serruys. Onassis Cardiac Center Course Book, 2003
  26. Sirolimus-eluting stents for restenosis following brachytherapy.
    CA.Arampatzis, G.Sianos, F.Saia, P.Lemos, A.Hoye, M.Degertekin, K.Tanabe, C.Lee, P.Smits, W.van derGiessen, P.deFeyter, R.vanDomburg,P.W.Serruys. Onassis cardiac center course book, 2003
  27. Do sirolimus-eluting stents reduce in-stent restenosis in diabetics?
    CA.Arampatzis, G.Sianos, P.Lemos, A.Hoye,F.Saia, M.Degertekin, K.Tanabe, C.Lee, P.C.SmitsW.van derGiessen, P.deFeyter, R.vanDomburgP.W.Serruys.  Onassis Cardiac Center Course Book, 2003
  28. Multi-slice spiral computed tomography. A glance at the future.
    CA.Arampatzis, K.Nieman, G.Sianos, F.CademartiriP.Lemos, R.Raaijmakers, N.Mollet, P.Patynama, P.W.Serruys, P.deFeyter. Onassis Cardiac Center Course Book, 2003
  29. Sirolimus-eluting stent implantation in the “real world”.
    CA.Arampatzis, G.Sianos, A. Hoye, P.Lemos, F.Saia,M.Degertekin, K.Tanabe, C.Lee, E.Regar, P.Smits, W. van derGiessen, P. deFeyter, R.vanDomburg, P.W.Serruys. Onassis Cardiac Center Course Book, 2003
  30. First experience with the sirolimus-eluting stent for the treatment of left main coronary artery disease.
    CA. Arampatzis, P Lemos, F Saia , A Hoye, P Smits, G Sianos, W van der Giessen, P de Feyter, PW Serruys. Hellenic Journal of Cardiology 2003; 44[suppl II]: A13 16
  31. Impact of the sirolimus-eluting stent in patients with acute myocardial infarction.
    CA. Arampatzis, F. Saia, P Lemos, M Degertekin, A Hoye, K Tanabe, P Smits, G Sianos, W van der Giessen, P de Feyter, PW Serruys. Hellenic Journal of Cardiology 2003; 44[suppl II]: A14 15
  32. Sirolimus-eluting stent in the “real world” of interventional cardiology.
    CA Arampatzis, P Lemos, F. Saia, M Degertekin, A Hoye, K Tanabe, P Smits, G Sianos, W van der Giessen, P de Feyter, PW Serruys. Hellenic Journal of Cardiology 2003; 44[suppl II]: A12 16
  33. Incidence of thrombotic occlusion in 563 consecutive patients treated with sirolimus-eluting stent.
    CA Arampatzis, P Lemos, F. Saia, M Degertekin, A Hoye, K Tanabe, P Smits, G Sianos, W van der Giessen, P de Feyter, PW Serruys. Hellenic Journal of Cardiology 2003; 44[suppl II]: A13 115
  34. The predispotition factors of atherosclerosis in patients with sleep apnea syndrome.
    Daskalopoulou E, Vlahogiannis E, Dougalis A, Balogianni M, Arampatzis CA, Kaitanidis S, Stiggas N, Patakas D. Hellenic journal of Medicine 63(suppl. 1): 36(109) 1997
  35. The frequency of sleep apnea syndrome in Greek professional drivers.
    Daskalopoulou E, Vlahogiannis E, Dougalis A, Fekete K, Kaitanidis S, Arampatzis CA, Andoniadou G, Stiggas N, Patakas. Hellenic Journal of Medicine 63 (suppl. 2): 117(87) 1997
  36.  The frequency of sleep apnea syndrome in workers in wood industry.
    Vlahogiannis E, Dougalis A, Balogianni M, Arampatzis CA, Nikokirakis A, Zahou K, Daskalopoulou E, Stiggas N. Pneumon journal suppl. 18(42) 1999
Play Video
Scroll Up